MMP9 and ovarian carcinoma: Up-regulated VCAN could also promote the invasion and movement of ovarian cancer cells by up-regulating CD44 and activating the NF-κB signaling pathway, matrix metalloproteinase 9 and hyaluronan-mediated movement receptors [36].